Electromedical Technologies annual ebitda
2019
2020
2021
2022
2023
Electromedical Technologies EBITDA Growth & History (EMED)
Electromedical Technologies's calculated EBITDA was −$2.1M for fiscal 2023.
View full Electromedical Technologies company overviewElectromedical Technologies annual ebitda history
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2023 | 2023-12-31 | −$2.1M | −$478,731 | — |
| 2022 | 2022-12-31 | −$1.6M | $2.2M | — |
| 2021 | 2021-12-31 | −$3.8M | −$633,575 | — |
| 2020 | 2020-12-31 | −$3.1M | −$1.5M | — |
| 2019 | 2019-12-31 | −$1.6M | — | — |
Electromedical Technologies quarterly ebitda
Q2.19
Q3.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
| Fiscal quarter | Period ended | EBITDA | Change | YoY change |
|---|---|---|---|---|
| Q3 2024 | 2024-09-30 | −$381,038 | −$142,009 | — |
| Q2 2024 | 2024-06-30 | −$251,845 | $89,558 | — |
| Q1 2024 | 2024-03-31 | −$154,876 | $1.1M | — |
| Q4 2023 | 2023-12-31 | −$222,971 | $28,893 | — |
| Q3 2023 | 2023-09-30 | −$239,029 | $92,878 | — |
| Q2 2023 | 2023-06-30 | −$341,403 | −$63,609 | — |
| Q1 2023 | 2023-03-31 | −$1.3M | −$536,893 | — |
| Q4 2022 | 2022-12-31 | −$251,864 | $1.2M | — |
| Q3 2022 | 2022-09-30 | −$331,907 | −$116,803 | — |
| Q2 2022 | 2022-06-30 | −$277,794 | $235,926 | — |
| Q1 2022 | 2022-03-31 | −$720,088 | $838,977 | — |
| Q4 2021 | 2021-12-31 | −$1.5M | −$1.7M | — |
| Q3 2021 | 2021-09-30 | −$215,104 | $1.9M | — |
| Q2 2021 | 2021-06-30 | −$513,720 | $298,720 | — |
| Q1 2021 | 2021-03-31 | −$1.6M | −$1.1M | — |
| Q4 2020 | 2020-12-31 | $189,393 | $362,401 | — |
| Q3 2020 | 2020-09-30 | −$2.1M | −$1.9M | — |
| Q2 2020 | 2020-06-30 | −$812,440 | — | — |
| Q1 2020 | 2020-03-31 | −$432,324 | — | — |
| Q3 2019 | 2019-09-30 | −$173,008 | — | — |
| Q2 2019 | 2019-06-30 | −$190,544 | — | — |
Electromedical Technologies ebitda trends
Across the available reported history, Electromedical Technologies's ebitda decreased from −$1.6M to −$2.1M, a change of −$478,731. The latest reported quarter, Q3 2024, shows −$381,038.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Electromedical Technologies filings at SEC.gov ↗